Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Psoriasis: Ustekinumab and Other Biologics in the Pipeline
Noori Kim,
Alice B. Gottlieb
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Psoriasis: Ustekinumab and Other Biologics in the Pipeline'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Psoriasis
100%
Psoriatic Arthritis
100%
Ustekinumab
100%
Psoriasis Treatment
50%
Clinical Trials
25%
Inflammatory Cytokines
25%
T Helper 17 (Th17)
25%
Interleukin-23 (IL-23)
25%
Biological Agents
25%
Drug Development
25%
Optimal Management
25%
Psoriasis Pathogenesis
25%
Immunology
25%
Quality of Life Issues
25%
Drug Research
25%
Therapeutic Utility
25%
Pathogenic T Cells
25%
Targeted Biologic Therapies
25%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Ustekinumab
100%
Biological Product
50%
Psoriatic Arthritis
50%
Cytokine
25%
Clinical Trial
25%
Interleukin 23
25%